Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Insider Trading Summary (Last 30 Days)

See how company executives and directors have been buying or selling shares over the past 30 days. Insider trading activity can help investors better understand company leadership's actions.

Transactions

0

Insider Involved

0

Total Buys

$0.00

Total Sells

$0.00

Insider Trading History (Last 12 Months)

Browse insider buying and selling activity reported to the SEC over the past year, including who traded, when they traded, and the value of each transaction.

No Insider Transactions found for OncoMed Pharmaceuticals Inc

Historical Insider Trading

View older insider trading records reported to the SEC to research long-term buying and selling trends.

DATE

INSIDER

INSIDER TYPE SHARES PRICE

SHARES

PRICE

VALUE

Dec 24, 2018

Gurney Austin

Gurney Austin
See Remarks
Sell
11,117 $0.60

11,117

$0.60

$6,669

Oct 10, 2018

Hager Alicia J.

Hager Alicia J.
SVP & General Counsel
Sell
1,156 $2.02

1,156

$2.02

$2,335

Oct 10, 2018

Lewicki John A.

Lewicki John A.
President & CEO
Sell
1,156 $2.01

1,156

$2.01

$2,324

Oct 10, 2018

Stagg Robert

Stagg Robert
SVP, Clinical R&D
Sell
927 $2.01

927

$2.01

$1,863

Oct 10, 2018

Li Yvonne

Li Yvonne
See Remarks
Sell
927 $2.02

927

$2.02

$1,873

Oct 10, 2018

Gurney Austin

Gurney Austin
See Remarks
Sell
1,156 $2.01

1,156

$2.01

$2,324

Oct 09, 2018

Hager Alicia J.

Hager Alicia J.
SVP & General Counsel
Sell
1,686 $2.13

1,686

$2.13

$3,589

Oct 09, 2018

Lewicki John A.

Lewicki John A.
President & CEO
Sell
2,296 $2.13

2,296

$2.13

$4,888

Oct 09, 2018

Stagg Robert

Stagg Robert
SVP, Clinical R&D
Sell
1,686 $2.13

1,686

$2.13

$3,589

Oct 09, 2018

Li Yvonne

Li Yvonne
See Remarks
Sell
1,229 $2.13

1,229

$2.13

$2,616

Oct 09, 2018

Gurney Austin

Gurney Austin
See Remarks
Sell
1,686 $2.13

1,686

$2.13

$3,589

Apr 24, 2018

Hager Alicia J.

Hager Alicia J.
SVP & General Counsel
Sell
4,051 $2.68

4,051

$2.68

$10,848

Apr 24, 2018

Lewicki John A.

Lewicki John A.
President & CEO
Sell
4,557 $2.68

4,557

$2.68

$12,202

Apr 24, 2018

Stagg Robert

Stagg Robert
SVP, Clinical R&D
Sell
4,051 $2.68

4,051

$2.68

$10,848

Apr 24, 2018

Li Yvonne

Li Yvonne
See Remarks
Sell
5,062 $2.68

5,062

$2.68

$13,555

Apr 24, 2018

Gurney Austin

Gurney Austin
See Remarks
Sell
4,051 $2.68

4,051

$2.68

$10,848

TOP